These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 327695)

  • 21. [Comparison of the plasmatic lipid pattern in obese diabetics before and after treatment with insulin and in non-diabetic obese persons: total lipids, triglycerides, phospholipids, alpha and beta lipoprotein cholesterol and single NEFA labeled with C 16-C 18].
    Bertolini AM; Santagostino A
    Minerva Med; 1973 Apr; 64(28):1486-95. PubMed ID: 4706998
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of treatment on blood lipid and blood acetoacetate levels in diabetes].
    Minamikawa Y; Tejima I; Arakawa M
    Iryo; 1968 Jul; 22(7):783-90. PubMed ID: 5702008
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 24. Cortisone nephropathy in the rabbit. The effect of heparin on the morphology, plasma lipid levels and plasma lipoprotein lipase activity.
    Rammer L; Nathorst-Windahl G; Boberg J
    Acta Pathol Microbiol Scand; 1967; 71(2):161-72. PubMed ID: 5582842
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lipoatrophic diabetes. A case description].
    Bozhadzhieva E; Konstantinov N; Rachev R; Koev D; Chankova P
    Vutr Boles; 1973; 12(1):130-3. PubMed ID: 4351186
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasmatic elimination of lipids and diabetes. Studies of lipoprotein lipase].
    Guisard D; Castro G; Debry G; Mullor JB
    C R Seances Soc Biol Fil; 1972; 166(8):1067-70. PubMed ID: 4660171
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test].
    Vailati G; Cuttica F; Montini M; Rebba A; Pagani G
    Clin Ter; 1974 Jan; 68(2):149-70. PubMed ID: 4596250
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interrelationship of a glucose tolerance disorder and the lipid level in the blood in diffuse toxic goiter during the treatment process].
    Zaripova ZKh
    Sov Med; 1978 Jun; (6):56-9. PubMed ID: 580978
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of lipoprotein lipase and effect of heparin on blood lipids in exogenous obesity.
    Miturzyńska-Stryjecka H
    Pol Med J; 1967; 6(6):1459-65. PubMed ID: 5582674
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic control and serum lipoproteins after total pancreatectomy.
    Kiviluoto T; Schröder T; Karonen SL; Kuusi T; Lempinen M; Taskinen MR
    Ann Clin Res; 1985; 17(3):110-5. PubMed ID: 4051443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes].
    Gervasini A
    Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monitoring of blood sugar levels during insulin treatment of diabetes mellitus].
    Chen JW
    Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):184-6. PubMed ID: 6432274
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R
    Nouv Presse Med; 1975 Feb; 4(7):500-1. PubMed ID: 1093131
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood sugar, insulin, and blood lipid disorders after oral administration of glucose and medium-chain triglycerides in diabetics].
    Ferlito S; Lo Furno F; Munaò F; Lunetta M
    Minerva Dietol Gastroenterol; 1978; 24(1):33-42. PubMed ID: 740266
    [No Abstract]   [Full Text] [Related]  

  • 37. Fasting lipid and glucose profiles in African diabetic and non-diabetic subjects in Mulago Hospital.
    Otim MA; Kyobe J
    East Afr Med J; 1979 May; 56(5):214-8. PubMed ID: 467290
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of methandrostenolone on serum triglyceride and cholesterol levels in diabetic patients.
    Romics L; Bretán M; Szigeti A; Varsányi-Nagy M
    Acta Med Acad Sci Hung; 1975; 32(1):27-34. PubMed ID: 1233859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical treatment results with glycodiazine].
    Fein C; Stemann G; Nusser E
    Med Welt; 1968 Sep; 36():1921-6. PubMed ID: 4887074
    [No Abstract]   [Full Text] [Related]  

  • 40. [Post-heparin blood lipolytic activity in patients with diabetes mellitus].
    Geller LI; Kozlova ZP
    Probl Endokrinol (Mosk); 1970; 16(4):23-6. PubMed ID: 5517110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.